Related Experiment Videos
10-Hydroxynortriptyline and treatment effects in elderly depressed patients
R E McCue1, A Georgotas, R F Suckow
1Department of Psychiatry, New York University School of Medicine, New York 10016.
The Journal of Neuropsychiatry and Clinical Neurosciences
|January 1, 1989
Summary
This study found that nortriptyline metabolite levels did not predict antidepressant response in elderly patients. However, lower levels of a specific isomer, E-10-hydroxynortriptyline, were linked to dizziness and orthostatic hypotension symptoms.
Area of Science:
- Pharmacology
- Geriatric Psychiatry
- Clinical Chemistry
Background:
- Nortriptyline is a tricyclic antidepressant used for treating depression.
- Understanding the relationship between drug metabolism and clinical outcomes is crucial for optimizing treatment.
- Elderly populations may exhibit altered drug metabolism and increased susceptibility to side effects.
Purpose of the Study:
- To investigate the correlation between plasma concentrations of nortriptyline and its metabolite, 10-hydroxynortriptyline, and clinical response in elderly depressed outpatients.
- To examine the relationship between specific nortriptyline metabolite isomers and reported side effects, particularly dizziness and orthostatic hypotension.
Main Methods:
- Sixty-four elderly outpatients diagnosed with depression were enrolled.
- Treatment involved nortriptyline for seven weeks.
- Weekly measurements of plasma nortriptyline and 10-hydroxynortriptyline levels were conducted.
- Correlation analyses were performed between metabolite levels and clinical response, as well as reported side effects.
Main Results:
- No significant correlation was found between 10-hydroxynortriptyline plasma levels and clinical response.
- Plasma levels of the trans isomer, E-10-hydroxynortriptyline, were significantly lower in patients reporting dizziness and orthostatic hypotension symptoms.
- A significant correlation between E-10-hydroxynortriptyline levels and actual orthostatic drop in systolic pressure was not observed.
- Plasma levels of 10-hydroxynortriptyline showed no significant correlation with other reported side effects.
Conclusions:
- Plasma levels of 10-hydroxynortriptyline do not appear to predict clinical antidepressant efficacy in elderly patients.
- Lower plasma concentrations of the E-10-hydroxynortriptyline isomer may be associated with specific side effects like dizziness and orthostatic hypotension symptoms in this population.
- Further research is warranted to explore the role of specific nortriptyline metabolites in predicting side effect profiles and guiding treatment adjustments in geriatric depression.